Camilo, Zerica .
HRN: 22-01-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2022
CEFTAZIDIME 1GM (VIAL)
12/20/2022
12/27/2022
IVT
140 Mg
8 Hrs
RT PCR Confirmed COVID 19 Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes